Additionally, the study compared Epi proColon® 2.0 CE test performance with the standard guaiac-based fecal occult blood test (gFOBT) and a serum-based tumor marker for CRC—carcinoembryonic antigen (CEA). Here, CEACAM5 is linked to neoplasm.